In FD fibroblasts, EED226 did not change the H3K27me3/H3 ratio (Fig 4C) and the ELP1 exon 20 splicing pattern (S3A Fig) suggesting that this antitumor drug acts preferentially on cancer-derived cells while sparing primary cells. Here, ELP1 is linked to cancer.